Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - TOTAL OTHER INCOME
Total Other Income KYMR - Kymera Therapeutics, Inc.
18.6 M
LAST VALUE
670.21%
2 YEAR CAGR
310.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR